Skip to content
Issue price
₹593
Listing price
₹730
+23.10%
Current price
₹1,198.7
+102.14%
Subscribed
93.72x
Issue size
₹895 Cr
Listed on
28 Nov 2025

IPO timeline

  1. Opens
    21 NovFri
  2. Closes
    25 NovTue
  3. Allotment
    26 NovWed
  4. Refunds
    27 NovThu
  5. Demat credit
    27 AugWed
  6. Listing
    28 NovFri

Issue details

Price band
₹563 – ₹593 per share
Issue size
₹895 Cr
Fresh issue
Not available
Offer for sale
Not available
Issue type
Fresh capital cum OFS
Face value
₹1 per share
Lot size
25 shares
Minimum investment
₹14,825
Listing on
BSE & NSE
Exchange code
SUDEEPPHRM.BO · 7455

This issue combines a fresh issue and an offer for sale. The amounts for each part are not available in our data; see the offer document for the split.

Lot size and investment

ApplicationLotsSharesAmount
Retail (Min)125₹14,825
Retail (Max)13325₹1,92,725
S-HNI (Min)14350₹2,07,550
B-HNI (Min)681,700₹10,08,100

Reservation

QIB
75,46,373 shares (50.00% of the Offer)
NII
22,63,913 shares (15.00% of the Offer)
Retail
52,82,463 shares (35.00% of the Offer)

Allotment status

Registrar: MUFG Intime India Private Limited

The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).

Check allotment on MUFG Intime India
  1. 1Open the registrar's allotment page and select this IPO from the list.
  2. 2Enter your PAN, application number or DP / Client ID.
  3. 3Submit to see the number of shares allotted, if any.
Basis of allotment
26 Nov 2025
Refunds initiated
27 Nov 2025
Shares credited to demat
27 Aug 2025
Listing
28 Nov 2025
Basis of allotment document

Grey market premium (GMP)

Updated 19 Nov 2025, 12:00 PM IST
Current GMP
₹93
+16.00%
Estimated listing price
₹686
Issue price ₹593
Kostak rate
₹0

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

Subscription status

Updated 08 Aug 2026, 04:05 PM IST
Overall subscription
93.72x
Fully subscribed · 28,85,745 applications
  • QIB213.08x
  • NII (HNI)116.72x
  • Retail15.65x
CategoryShares offeredShares bid forSubscribed
Qualified Institutional Buyers (QIB)30,18,55064,31,88,450213.08x
Non-Institutional Investors (NII)22,63,91326,42,40,450116.72x
bNII — bids above ₹10 Lakh15,09,27620,36,19,700134.91x
sNII — bids ₹2 Lakh to ₹10 Lakh7,54,6376,06,20,75080.33x
Retail Individual Investors (RII)52,82,4638,26,71,25015.65x
Total1,05,64,92699,01,00,15093.72x

Financials

Amounts in Rs. Crore
P/E Ratio
53.55
EPS (₹)
11.07
RoCE
35
RoNW
27.88
PAT Margin
27.63

Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.

Period ended31 Mar 2431 Mar 2331 Mar 22
Revenue565.55959.21475.51
OPM %7.65
EBITDA84.11107.9757.82
Net Profit-16.98-102.35-71.70
Debt533.51437.06384.79
Assets2,134.351,859.841,863.50
CompanyIssue sizeP/ERoNWPAT marginSubscribedListing gain
Sudeep Pharma
This IPO
₹895 Cr53.5527.88%27.63%93.72x+23.10%
Nephrocare Health Services
Mainboard · listed 17 Dec 2025
₹871.05 Cr162.1913.19%8.88%13.96x+6.52%
Park Medi World
Mainboard · listed 17 Dec 2025
₹920 Cr63.5213.19%8.88%8.1x-1.98%
Ellenbarrie Industrial Gases
Mainboard · listed 1 Jul 2025
₹852.53 Cr67.6924.97%23.90%22.47x+21.50%
Molbio Diagnostics
Mainboard · listed 17 Aug 2026
₹939.7 Cr56.6714.55%11.28%70.26x+21.44%
Suraksha Diagnostic
Mainboard · listed 6 Dec 2024
₹846.25 Cr74.8914.09%10.57%1.27x-0.68%
Fusion CX
Mainboard · listed 22 Oct 2026
₹702 Cr18.739.12%11.36%4.45x+5.54%

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

IPO objectives

₹88.48 Cr total

How Sudeep Pharma plans to use the money raised, as stated in the offer document.

  1. Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I ₹75.81 Cr
  2. General corporate purposes₹12.67 Cr

About Sudeep Pharma

Sudeep Pharma Limited is an India-based pharmaceutical company known for its specialization in mineral-based excipients and active ingredients used across pharma, nutraceutical, and food industries. Established with a focus on quality and innovation, the company has built a strong presence over the years by catering to both domestic and international markets. Promoted by experienced industry professionals, Sudeep Pharma has developed deep technical expertise and a reputation for consistent product standards, regulatory compliance, and customer-centric operations. The company primarily manufactures calcium-based and mineral ingredients such as calcium carbonate, calcium citrate, and other specialty compounds widely used in tablets, dietary supplements, and fortified food products. Its business model is largely B2B, supplying to pharmaceutical companies, nutraceutical brands, and global distributors. By focusing on quality certifications, scalable manufacturing, and long-term client relationships, the company aims to sustain growth and expand its footprint in regulated and semi-regulated markets worldwide.

Promoters and shareholding

Avani Sujit Bhayani, Bhayani Family Trust, Riva Resources Pvt.Ltd, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani (HUF), Sujit Jaysukh Bhayani

Promoter holding, pre-issue
89.37%
Promoter holding, post-issue
76.15%

Registrar, lead managers and documents

Registrar

MUFG Intime India Private Limited

+91-22-4918 6270

sudeeppharma.ipo@in.mpms.mufg.com

Company contact

129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340

+91 265 284 0656

cs.sudeep@sudeepgroup.com

Sudeep Pharma IPO: common questions

1.When does the Sudeep Pharma IPO open and close?

The Sudeep Pharma IPO opens on 21 Nov 2025 and closes on 25 Nov 2025.

2.What is the price band of the Sudeep Pharma IPO?

The price band is ₹563 – ₹593 per share, with a lot size of 25 shares and a minimum investment of ₹14,825.

3.What is the size of the Sudeep Pharma IPO?

The issue size is ₹895 Cr (Fresh capital cum OFS).

4.What is the GMP of the Sudeep Pharma IPO?

The last reported grey market premium is ₹93 per share as of 19 Nov 2025, 12:00 PM IST. GMP is unofficial and changes frequently.

5.When is the Sudeep Pharma IPO allotment?

The basis of allotment is expected on 26 Nov 2025. Allotment status can be checked with the registrar, MUFG Intime India Private Limited.

6.When will the Sudeep Pharma IPO list?

The shares listed on 28 Nov 2025 on BSE & NSE.

7.Who is the lead manager of the Sudeep Pharma IPO?

The book running lead managers are ICICI Securities, IIFL Capital Services Limited, and the registrar is MUFG Intime India Private Limited.

8.What will the money raised in the Sudeep Pharma IPO be used for?

As stated in the offer document, the proceeds are for: Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I ; General corporate purposes.

9.How can my company launch an IPO like Sudeep Pharma?

Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.

For business owners

Your company could be the next listing

Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.

  • Eligibility check against NSE Emerge, BSE SME and Main Board norms
  • Indicative valuation and issue size for your business
  • A clear timeline from readiness to listing day

Check if your business can list

Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.

Prefer to talk? Call +91 92130 20393